Chunlai Nie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chunlai Nie has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Xinyu Liu
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, 610041, Chengdu, China
4 shared publicationsYu Zhang
Department of Oncology, Guizhou People's Hospital, 550002, Guizhou, China
4 shared publicationsFang Wang
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, 610041, Chengdu, China
3 shared publicationsZhu Yuan
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China
3 shared publicationsGuanghou Shui
State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, 100101, Beijing, China
2 shared publicationsHang Zhou
Department of Chemotherapy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
2 shared publications
Latest Publications
- Open Access
- 13 November 2018
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (11) , 1127
Correction: Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion
The work was supported by the Natural Science Foundation of China (NSFC)-81773188, 81760557, 81703081, and Program for New Century Excellent Talents in University (NCET)-12-0381. And we would like to appreciate the help given to the work by the lab of Prof. Fuyu Yang’s from Institute of Biophysics and Prof. Yaping Tu from Creighton University in USA
- 13 November 2018
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (11) , 1127
Open AccessCorrection: Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion
The work was supported by the Natural Science Foundation of China (NSFC)-81773188, 81760557, 81703081, and Program for New Century Excellent Talents in University (NCET)-12-0381. And we would like to appreciate the help given to the work by the lab of Prof. Fuyu Yang’s from Institute of Biophysics and Prof. Yaping Tu from Creighton University in USA
- Open Access
- 26 October 2017
- Published by Springer Nature in Cell Death & Disease
- Vol. 8 (10) , e3151
Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion
Guanylate-binding protein 2 (GBP2) is a member of the large GTPase superfamily that is strongly induced by interferon-γ (IFN-γ). Although the biochemical characteristics of GBP2 have been reported in detail, its biological function has not been thoroughly elucidated to date. To the best of our knowledge, this study presents the first demonstration that GBP2 inhibits mitochondrial fission and cell metastasis in breast cancer cells both in vitro and in vivo. Our previous work demonstrated that dynamin-related protein 1 (Drp1)-dependent mitochondrial fission has a key role in breast cancer cell invasion. In this study, we demonstrate that GBP2 binds directly to Drp1. Elimination of Drp1 by shRNA or Mdivi-1 (a Drp1-specific inhibitor) suppressed GBP2’s regulatory function. Furthermore, GBP2 blocks Drp1 translocation from the cytosol to mitochondria, thereby attenuating Drp1-dependent mitochondrial fission and breast cancer cell invasion. In summary, our data provide new insights into the function and molecular mechanisms underlying GBP2’s regulation of breast cancer cell invasion.
- 26 October 2017
- Published by Springer Nature in Cell Death & Disease
- Vol. 8 (10) , e3151
Open AccessGuanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion
Guanylate-binding protein 2 (GBP2) is a member of the large GTPase superfamily that is strongly induced by interferon-γ (IFN-γ). Although the biochemical characteristics of GBP2 have been reported in detail, its biological function has not been thoroughly elucidated to date. To the best of our knowledge, this study presents the first demonstration that GBP2 inhibits mitochondrial fission and cell metastasis in breast cancer cells both in vitro and in vivo. Our previous work demonstrated that dynamin-related protein 1 (Drp1)-dependent mitochondrial fission has a key role in breast cancer cell invasion. In this study, we demonstrate that GBP2 binds directly to Drp1. Elimination of Drp1 by shRNA or Mdivi-1 (a Drp1-specific inhibitor) suppressed GBP2’s regulatory function. Furthermore, GBP2 blocks Drp1 translocation from the cytosol to mitochondria, thereby attenuating Drp1-dependent mitochondrial fission and breast cancer cell invasion. In summary, our data provide new insights into the function and molecular mechanisms underlying GBP2’s regulation of breast cancer cell invasion.
- Open Access
- 23 August 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (46) , 80770-80789
PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines
PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines
- 23 August 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (46) , 80770-80789
Open AccessPP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines
PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines
- Open Access
- 26 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (7) , 11042-11052
Mcl-1 expression and JNK activation induces a threshold for apoptosis in Bcl-xL-overexpressing hematopoietic cells
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Yu Zhang1, *, Xin Li1, *, Shisheng Tan1, Xinyu Liu2, Xinyu Zhao2, Zhu Yuan2, Chunlai Nie2 1Departmant of Oncology, Guizhou People’s Hospital, Guizhou, China 2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China *These authors contributed equally to this work Correspondence to: Chunlai Nie, email: niecl1022@hotmail.com Shisheng Tan, email: tssh18018@126.com Keywords: 2-DG, ABT-199, Apoptosis, Bcl-xL, Mcl-1 Received: November 02, 2016 Accepted: December 20, 2016 Published: December 26, 2016
- 26 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (7) , 11042-11052
Open AccessMcl-1 expression and JNK activation induces a threshold for apoptosis in Bcl-xL-overexpressing hematopoietic cells
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Yu Zhang1, *, Xin Li1, *, Shisheng Tan1, Xinyu Liu2, Xinyu Zhao2, Zhu Yuan2, Chunlai Nie2 1Departmant of Oncology, Guizhou People’s Hospital, Guizhou, China 2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China *These authors contributed equally to this work Correspondence to: Chunlai Nie, email: niecl1022@hotmail.com Shisheng Tan, email: tssh18018@126.com Keywords: 2-DG, ABT-199, Apoptosis, Bcl-xL, Mcl-1 Received: November 02, 2016 Accepted: December 20, 2016 Published: December 26, 2016
- Open Access
- 15 October 2015
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (10) , e1919
Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner
Chemoresistance in cancer has previously been attributed to gene mutations or deficiencies. Bax or p53 deficiency can lead to resistance to cancer drugs. We aimed to find an agent to overcome chemoresistance induced by Bax or p53 deficiency. Here, we used immunoblot, flow-cytometry analysis, gene interference, etc. to show that genistein, a major component of isoflavone that is known to have anti-tumor activities in a variety of models, induces Bax/p53-independent cell death in HCT116 Bax knockout (KO), HCT116 p53 KO, DU145 Bax KO, or DU145 p53 KO cells that express wild-type (WT) Bak. Bak knockdown (KD) only partially attenuated genistein-induced apoptosis. Further results indicated that the release of AIF and endoG also contributes to genistein-induced cell death, which is independent of Bak activation. Conversely, AIF and endoG knockdown had little effect on Bak activation. Knockdown of either AIF or endoG alone could not efficiently inhibit apoptosis in cells treated with genistein, whereas an AIF, endoG, and Bak triple knockdown almost completely attenuated apoptosis. Next, we found that the Akt-Bid pathway mediates Bak-induced caspase-dependent and AIF- and endoG-induced caspase-independent cell death. Moreover, downstream caspase-3 could enhance the release of AIF and endoG as well as Bak activation via a positive feedback loop. Taken together, our data elaborate the detailed mechanisms of genistein in Bax/p53-independent apoptosis and indicate that caspase-3-enhanced Bid activation initiates the cell death pathway. Our results also suggest that genistein may be an effective agent for overcoming chemoresistance in cancers with dysfunctional Bax and p53.
- 15 October 2015
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (10) , e1919
Open AccessCaspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner
Chemoresistance in cancer has previously been attributed to gene mutations or deficiencies. Bax or p53 deficiency can lead to resistance to cancer drugs. We aimed to find an agent to overcome chemoresistance induced by Bax or p53 deficiency. Here, we used immunoblot, flow-cytometry analysis, gene interference, etc. to show that genistein, a major component of isoflavone that is known to have anti-tumor activities in a variety of models, induces Bax/p53-independent cell death in HCT116 Bax knockout (KO), HCT116 p53 KO, DU145 Bax KO, or DU145 p53 KO cells that express wild-type (WT) Bak. Bak knockdown (KD) only partially attenuated genistein-induced apoptosis. Further results indicated that the release of AIF and endoG also contributes to genistein-induced cell death, which is independent of Bak activation. Conversely, AIF and endoG knockdown had little effect on Bak activation. Knockdown of either AIF or endoG alone could not efficiently inhibit apoptosis in cells treated with genistein, whereas an AIF, endoG, and Bak triple knockdown almost completely attenuated apoptosis. Next, we found that the Akt-Bid pathway mediates Bak-induced caspase-dependent and AIF- and endoG-induced caspase-independent cell death. Moreover, downstream caspase-3 could enhance the release of AIF and endoG as well as Bak activation via a positive feedback loop. Taken together, our data elaborate the detailed mechanisms of genistein in Bax/p53-independent apoptosis and indicate that caspase-3-enhanced Bid activation initiates the cell death pathway. Our results also suggest that genistein may be an effective agent for overcoming chemoresistance in cancers with dysfunctional Bax and p53.
- Open Access
- 23 April 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (19) , 17192-17205
Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death
Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death
- 23 April 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (19) , 17192-17205
Open AccessMitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death
Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death
- Open Access
- 30 October 2014
- Published by Springer Nature in Cell Death & Disease
- Vol. 5 (10) , e1495
Caspase-9 mediates Puma activation in UCN-01-induced apoptosis
The protein kinase inhibitor 7-hydroxystaurosporine (UCN-01) is one of the most potent and frequently used proapoptotic stimuli. The BH3-only molecule of Bcl-2 family proteins has been reported to contribute to UCN-01-induced apoptosis. Here we have found that UCN-01 triggers Puma-induced mitochondrial apoptosis pathway. Our data confirmed that Akt-FoxO3a pathway mediated Puma activation. Importantly, we elucidate the detailed mechanisms of Puma-induced apoptosis. Our data have also demonstrated that caspase-9 is a decisive molecule of Puma induction after UCN-01 treatment. Caspase-9 mediates apoptosis through two kinds of feedback loops. On the one hand, caspase-9 enhances Puma activation by cleaving Bcl-2 and Bcl-xL independent of caspase-3. On the other hand, caspase-9 directly activated caspase-3 in the presence of caspase-3. Caspase-3 could cleave XIAP in an another positive feedback loop to further sensitize cancer cells to UCN-01-induced apoptosis. Therefore, caspase-9 mediates Puma activation to determine the threshold for overcoming chemoresistance in cancer cells.
- 30 October 2014
- Published by Springer Nature in Cell Death & Disease
- Vol. 5 (10) , e1495
Open AccessCaspase-9 mediates Puma activation in UCN-01-induced apoptosis
The protein kinase inhibitor 7-hydroxystaurosporine (UCN-01) is one of the most potent and frequently used proapoptotic stimuli. The BH3-only molecule of Bcl-2 family proteins has been reported to contribute to UCN-01-induced apoptosis. Here we have found that UCN-01 triggers Puma-induced mitochondrial apoptosis pathway. Our data confirmed that Akt-FoxO3a pathway mediated Puma activation. Importantly, we elucidate the detailed mechanisms of Puma-induced apoptosis. Our data have also demonstrated that caspase-9 is a decisive molecule of Puma induction after UCN-01 treatment. Caspase-9 mediates apoptosis through two kinds of feedback loops. On the one hand, caspase-9 enhances Puma activation by cleaving Bcl-2 and Bcl-xL independent of caspase-3. On the other hand, caspase-9 directly activated caspase-3 in the presence of caspase-3. Caspase-3 could cleave XIAP in an another positive feedback loop to further sensitize cancer cells to UCN-01-induced apoptosis. Therefore, caspase-9 mediates Puma activation to determine the threshold for overcoming chemoresistance in cancer cells.
- Open Access
- 1 January 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (1) , 68-80
Proapoptotic Protein Smac Mediates Apoptosis in Cisplatin-resistant Ovarian Cancer Cells When Treated with the Anti-tumor Agent AT101
- 1 January 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (1) , 68-80
Open AccessProapoptotic Protein Smac Mediates Apoptosis in Cisplatin-resistant Ovarian Cancer Cells When Treated with the Anti-tumor Agent AT101